menu
    • menu

    Company profile for Pyros Pharmaceuticals

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Pyros Pharmaceuticals develops high-quality, proprietary specialty pharmaceuticals for rare diseases with high unmet needs. Research and development are the cornerstones of our growth strategy. Providing quality products through scientific innovations and precision medicine is the goal of all of Pyros’ research programs. The company's products include solid oral capsules, sterile injectable syringes, and alternative dosage f...
    Pyros Pharmaceuticals develops high-quality, proprietary specialty pharmaceuticals for rare diseases with high unmet needs. Research and development are the cornerstones of our growth strategy. Providing quality products through scientific innovations and precision medicine is the goal of all of Pyros’ research programs. The company's products include solid oral capsules, sterile injectable syringes, and alternative dosage form ANDAs, developed through scientific innovations and research, enabling pharmaceutical companies to provide affordable and accessible alternatives to high-cost off-patent pharmaceutical products.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Pyros PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2001 Route 46, Suite 310 Parsippany, NJ 07054
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://pyrospharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/pyrospharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pantherx Rare: Upsher-Smith Picks It For Vigafyde Oral Solution
    Pantherx Rare: Upsher-Smith Picks It For Vigafyde Oral Solution

    24 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/pantherx-rare-selected-by-upsher-smith-laboratories-llc-as-specialty-pharmacy-for-vigafyde-vigabatrin-oral-solution-302409343.html

    PR NEWSWIRE
    24 Mar 2025
    Share Share
    Bora to Expand Rare Disease Portfolio with Acquisition of Pyros
    Bora to Expand Rare Disease Portfolio with Acquisition of Pyros

    26 Oct 2024

    // PRESS RELEASE

    https://bora-corp.com/bora-pharmaceuticals-to-expand-rare-disease-portfolio-with-acquisition-of-us-based-pyros-pharmaceuticals/

    PRESS RELEASE
    26 Oct 2024
    Share Share
    Pyros Pharmaceuticals Launches VIGAFYDE, Ready-to-Use Vigabatrin Solution
    Pyros Pharmaceuticals Launches VIGAFYDE, Ready-to-Use Vigabatrin Solution

    03 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240903986205/en

    BUSINESSWIRE
    03 Sep 2024
    Share Share
    Pyros Pharma Abstract Accepted For Poster At AES 2024 Annual Meeting
    Pyros Pharma Abstract Accepted For Poster At AES 2024 Annual Meeting

    20 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240820279868/en

    BUSINESSWIRE
    20 Aug 2024
    Share Share
    Pyros Pharma's Vigafyde (vigabatrin) Receives Approval in the U.S
    Pyros Pharma's Vigafyde (vigabatrin) Receives Approval in the U.S

    20 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217684

    FDA
    20 Jun 2024
    Share Share
    Pyros Pharmaceuticals Announces FDA Approval of VIGAFYDE™
    Pyros Pharmaceuticals Announces FDA Approval of VIGAFYDE™

    18 Jun 2024

    // BIOSPACE

    https://www.biospace.com/article/releases/pyros-pharmaceuticals-announces-fda-approval-of-vigafyde-vigabatrin-as-the-first-and-only-ready-to-use-vigabatrin-oral-solution/

    BIOSPACE
    18 Jun 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search